PubMed:12975616
Annnotations
GlyCosmos15-Species
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 2 | 0-4 | Species | denotes | Mice | 10090 |
| 35 | 678-682 | Species | denotes | mice | 10090 |
| 38 | 712-716 | Species | denotes | mice | 10090 |
| 40 | 874-878 | Species | denotes | mice | 10090 |
| 44 | 1111-1115 | Species | denotes | mice | 10090 |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 18-33 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
| T2 | 114-129 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | Heparan sulfate |
| T3 | 202-217 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
| T4 | 443-458 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 948-979 | HP_0001511 | denotes | intrauterine growth retardation |
| T2 | 961-979 | HP_0001510 | denotes | growth retardation |
| T3 | 1020-1032 | HP_0003256 | denotes | coagulopathy |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-113 | Sentence | denotes | Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes. |
| TextSentencer_T2 | 114-330 | Sentence | denotes | Heparan sulfate that contains antithrombin binding sites is designated as anticoagulant heparan sulfate (HS(act)) since, in vitro, it dramatically enhances the neutralization of coagulation proteases by antithrombin. |
| TextSentencer_T3 | 331-491 | Sentence | denotes | Endothelial cell production of HS(act) is controlled by the Hs3st1 gene, which encodes the rate limiting enzyme-heparan sulfate 3-O-sulfotransferase-1 (Hs3st1). |
| TextSentencer_T4 | 492-590 | Sentence | denotes | It has long been proposed that levels of endothelial HS(act) may tightly regulate hemostatic tone. |
| TextSentencer_T5 | 591-683 | Sentence | denotes | This potential in vivo role of HS(act) was assessed by generating Hs3st1(-/-) knockout mice. |
| TextSentencer_T6 | 684-804 | Sentence | denotes | Hs3st1(-/-) and Hs3st1(+/+) mice were evaluated with a variety of methods, capable of detecting altered hemostatic tone. |
| TextSentencer_T7 | 805-852 | Sentence | denotes | However, both genotypes were indistinguishable. |
| TextSentencer_T8 | 853-980 | Sentence | denotes | Instead, Hs3st1(-/-) mice exhibited lethality on a specific genetic background and also showed intrauterine growth retardation. |
| TextSentencer_T9 | 981-1033 | Sentence | denotes | Neither phenotypes result from a gross coagulopathy. |
| TextSentencer_T10 | 1034-1162 | Sentence | denotes | So although this enzyme produces the majority of tissue HS(act), Hs3st1(-/-) mice do not show an obvious procoagulant phenotype. |
| TextSentencer_T11 | 1163-1326 | Sentence | denotes | These results suggest that the bulk of HS(act) is not essential for normal hemostasis and that hemostatic tone is not tightly regulated by total levels of HS(act). |
| TextSentencer_T12 | 1327-1477 | Sentence | denotes | Moreover, the unanticipated non-thrombotic phenotypes suggest structure(s) derived from this enzyme might serve additional/alternative biologic roles. |
| T1 | 0-113 | Sentence | denotes | Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes. |
| T2 | 114-330 | Sentence | denotes | Heparan sulfate that contains antithrombin binding sites is designated as anticoagulant heparan sulfate (HS(act)) since, in vitro, it dramatically enhances the neutralization of coagulation proteases by antithrombin. |
| T3 | 331-491 | Sentence | denotes | Endothelial cell production of HS(act) is controlled by the Hs3st1 gene, which encodes the rate limiting enzyme-heparan sulfate 3-O-sulfotransferase-1 (Hs3st1). |
| T4 | 492-590 | Sentence | denotes | It has long been proposed that levels of endothelial HS(act) may tightly regulate hemostatic tone. |
| T5 | 591-683 | Sentence | denotes | This potential in vivo role of HS(act) was assessed by generating Hs3st1(-/-) knockout mice. |
| T6 | 684-804 | Sentence | denotes | Hs3st1(-/-) and Hs3st1(+/+) mice were evaluated with a variety of methods, capable of detecting altered hemostatic tone. |
| T7 | 805-852 | Sentence | denotes | However, both genotypes were indistinguishable. |
| T8 | 853-980 | Sentence | denotes | Instead, Hs3st1(-/-) mice exhibited lethality on a specific genetic background and also showed intrauterine growth retardation. |
| T9 | 981-1033 | Sentence | denotes | Neither phenotypes result from a gross coagulopathy. |
| T10 | 1034-1162 | Sentence | denotes | So although this enzyme produces the majority of tissue HS(act), Hs3st1(-/-) mice do not show an obvious procoagulant phenotype. |
| T11 | 1163-1326 | Sentence | denotes | These results suggest that the bulk of HS(act) is not essential for normal hemostasis and that hemostatic tone is not tightly regulated by total levels of HS(act). |
| T12 | 1327-1477 | Sentence | denotes | Moreover, the unanticipated non-thrombotic phenotypes suggest structure(s) derived from this enzyme might serve additional/alternative biologic roles. |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 948-979 | Disease | denotes | intrauterine growth retardation | http://purl.obolibrary.org/obo/MONDO_0005030 |
| T2 | 1020-1032 | Disease | denotes | coagulopathy | http://purl.obolibrary.org/obo/MONDO_0001531 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 948-979 | Phenotype | denotes | intrauterine growth retardation | HP:0001511 |
| T2 | 1020-1032 | Phenotype | denotes | coagulopathy | HP:0003256 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 948-979 | Phenotype | denotes | intrauterine growth retardation | HP:0001511 |
| T2 | 1020-1032 | Phenotype | denotes | coagulopathy | HP:0003256 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-113 | Sentence | denotes | Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes. |
| T2 | 114-330 | Sentence | denotes | Heparan sulfate that contains antithrombin binding sites is designated as anticoagulant heparan sulfate (HS(act)) since, in vitro, it dramatically enhances the neutralization of coagulation proteases by antithrombin. |
| T3 | 331-491 | Sentence | denotes | Endothelial cell production of HS(act) is controlled by the Hs3st1 gene, which encodes the rate limiting enzyme-heparan sulfate 3-O-sulfotransferase-1 (Hs3st1). |
| T4 | 492-590 | Sentence | denotes | It has long been proposed that levels of endothelial HS(act) may tightly regulate hemostatic tone. |
| T5 | 591-683 | Sentence | denotes | This potential in vivo role of HS(act) was assessed by generating Hs3st1(-/-) knockout mice. |
| T6 | 684-804 | Sentence | denotes | Hs3st1(-/-) and Hs3st1(+/+) mice were evaluated with a variety of methods, capable of detecting altered hemostatic tone. |
| T7 | 805-852 | Sentence | denotes | However, both genotypes were indistinguishable. |
| T8 | 853-980 | Sentence | denotes | Instead, Hs3st1(-/-) mice exhibited lethality on a specific genetic background and also showed intrauterine growth retardation. |
| T9 | 981-1033 | Sentence | denotes | Neither phenotypes result from a gross coagulopathy. |
| T10 | 1034-1162 | Sentence | denotes | So although this enzyme produces the majority of tissue HS(act), Hs3st1(-/-) mice do not show an obvious procoagulant phenotype. |
| T11 | 1163-1326 | Sentence | denotes | These results suggest that the bulk of HS(act) is not essential for normal hemostasis and that hemostatic tone is not tightly regulated by total levels of HS(act). |
| T12 | 1327-1477 | Sentence | denotes | Moreover, the unanticipated non-thrombotic phenotypes suggest structure(s) derived from this enzyme might serve additional/alternative biologic roles. |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 948-979 | Disease | denotes | intrauterine growth retardation | MONDO:0005030 |
| T2 | 1020-1032 | Disease | denotes | coagulopathy | MONDO:0001531 |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 18-33 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
| T2 | 114-129 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
| T3 | 202-217 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
| T4 | 443-458 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 0-4 | OrganismTaxon | denotes | Mice | 10088 |
| T2 | 678-682 | OrganismTaxon | denotes | mice | 10088 |
| T3 | 712-716 | OrganismTaxon | denotes | mice | 10088 |
| T4 | 874-878 | OrganismTaxon | denotes | mice | 10088 |
| T5 | 1111-1115 | OrganismTaxon | denotes | mice | 10088 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 331-347 | Body_part | denotes | Endothelial cell | http://purl.obolibrary.org/obo/CL_0000115 |
| T2 | 1083-1089 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 331-347 | Cell | denotes | Endothelial cell | http://purl.obolibrary.org/obo/CL:0000115 |